Niva Bupa Health Insurance Company Limited (NSE:NIVABUPA)
India · Delayed Price · Currency is INR 71.95
-1.58 (-2.15%)
Oct 22, 2026, 3:29 PM IST
NSE:NIVABUPA Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, NSE:NIVABUPA stock has a consensus rating of "Buy" and an average price target of ₹99.09. The average 1-year stock price forecast is 37.72% higher than the current stock price, while the lowest is ₹90.00 (+25.09%) and the highest is ₹105.00 (+45.93%).
Price Target: ₹99.09 (+37.72%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NSE:NIVABUPA stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Buy | 5 | 6 | 6 | 7 | 7 | 7 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains ₹105.00 → ₹95.00 | Buy | Maintains | ₹105.00 → ₹95.00 | +32.04% | Oct 8, 2026 |
| Motilal Oswal | Motilal Oswal | Buy Maintains ₹100.00 | Buy | Maintains | ₹100.00 | +38.99% | Sep 24, 2026 |
Financial Forecast
Revenue This Year
98.87B
from 84.43B
Increased by 17.10%
Revenue Next Year
122.20B
from 98.87B
Increased by 23.60%
EPS This Year
2.64
from 0.71
Increased by 271.55%
EPS Next Year
3.38
from 2.64
Increased by 28.17%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.